EUVIMEDEUVIMED entdecken
Crossref

Risk of Hepatocellular Carcinoma Decreases After Antiviral Therapy–Induced HBsAg Seroclearance

Han Ah Lee iD, Hyun Woong Lee, Yeon Seok Seo iD, Dong Hyun Sinn iD, Sang Hoon Ahn iD, Beom Kyung Kim iD, Seung Up Kim iD

Journal of Gastroenterology and Hepatology · 2025

DOI: 10.1111/jgh.16973 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, 2025. Verfasst von Han Ah Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Antiviral Agents, Hepatitis B Surface Antigens. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Ministry of Science and ICT, South Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Antiviral therapy (AVT) reduces the risk of hepatitis B virus–related hepatocellular carcinoma (HCC).

Aims

The difference in risk of HCC after hepatitis B surface antigen (HBsAg) seroclearance to the AVT status was explored.

Methods

Patients with chronic hepatitis B who achieved HBsAg seroclearance were retrospectively evaluated. The primary outcome was the development of HCC after HBsAg seroclearance.

Results

Of the study population, 1280 (84.2%) and 241 (15.8%) patients achieved HBsAg seroclearance without (spontaneous clearance group) and with AVT (AVT‐induced clearance group), respectively. HCC cumulative incidence was comparable between the two groups (hazard ratio [HR] = 0.461; log‐rank test, p = 0.197), whereas it was significantly lower in the AVT‐induced HBsAg clearance group than in the spontaneous HBsAg clearance group in inverse probability of treatment weighting analysis (HR = 0.442; log‐rank test, p = 0.004). In multivariate analysis, spontaneous HBsAg clearance, albumin–bilirubin (ALBI) grade ≥ 2, cirrhosis, and platelet count < 50 × 10 9 /L were independently associated with the increased risk of HCC. The newly established antiviral therapy, cirrhosis, ALBI, and platelet count (ACAP) scores had a C‐index of 0.765, and the time‐dependent areas under the curve of HCC prediction at 5 and 8 years were 0774 and 0.823, respectively.

Conclusion

The risk of HCC differed according to the AVT status after HBsAg seroclearance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsAntiviral AgentsHepatitis B Surface AntigensHepatitis B, ChronicHumansMaleFemaleMiddle AgedRetrospective StudiesIncidenceAgedRisk FactorsAdultTreatment Outcome

Stichwörter der Autor:innen

antiviral therapyhepatitis B surface antigenhepatocellular carcinomaprediction model

Substanzen

Antiviral AgentsHepatitis B Surface Antigens

Autor:innen und Institutionen

  • Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea.
  • Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
  • Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
  • Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Yonsei Liver Center, Severance Hospital, Seoul, South Korea.

ORCID-Profile: Han Ah Lee, Yeon Seok Seo, Dong Hyun Sinn, Sang Hoon Ahn, Beom Kyung Kim, Seung Up Kim

Förderung

  • Ministry of Science and ICT, South Korea

Zitieren

APA

Lee, H. A., Lee, H. W., Seo, Y. S., Sinn, D. H., Ahn, S. H., Kim, B. K., & Kim, S. U. (2025). Risk of Hepatocellular Carcinoma Decreases After Antiviral Therapy–Induced HBsAg Seroclearance. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16973

Vancouver

Lee HA, Lee HW, Seo YS, Sinn DH, Ahn SH, Kim BK, et al. Risk of Hepatocellular Carcinoma Decreases After Antiviral Therapy–Induced HBsAg Seroclearance. Journal of Gastroenterology and Hepatology. 2025. doi:10.1111/jgh.16973

BibTeX
@article{Lee2025,
  author = {Lee, Han Ah and Lee, Hyun Woong and Seo, Yeon Seok and Sinn, Dong Hyun and Ahn, Sang Hoon and Kim, Beom Kyung and Kim, Seung Up},
  title = {Risk of Hepatocellular Carcinoma Decreases After Antiviral Therapy–Induced HBsAg Seroclearance},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2025},
  doi = {10.1111/jgh.16973}
}
Kostenlos starten →